It is well established that DLBCL and CLL cells display chronic BCR signaling, leading to constitutive activation of different signaling pathways, including the PLCγ2 pathway, which leads to the production of IP3 in basal conditions [23–25]. Here, PLCG2 is linked to B-cell chronic lymphocytic leukemia.